Stay updated on Finerenone in HF with LVEF ≥40% Clinical Trial
Sign up to get notified when there's something new on the Finerenone in HF with LVEF ≥40% Clinical Trial page.

Latest updates to the Finerenone in HF with LVEF ≥40% Clinical Trial page
- Check2 days agoChange DetectedThe site revision label changes from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check8 days agoChange DetectedA site-wide NIH notice appears above the ClinicalTrials.gov page, announcing updates about terminology used during a transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check16 days agoChange DetectedThe footer’s displayed site revision changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check23 days agoChange DetectedThe site footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check37 days agoChange DetectedA 403 Forbidden error page is now displayed for the study record, showing a 403 message and a Home button. This indicates access to the study content is blocked rather than the study details being shown.SummaryDifference16%

- Check44 days agoChange DetectedRevision: v3.7.0 was added to indicate an updated page version. A citation related to Finerenone QoL and the older revision tag v3.6.6 were removed.SummaryDifference0.0%

Stay in the know with updates to Finerenone in HF with LVEF ≥40% Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Finerenone in HF with LVEF ≥40% Clinical Trial page.